Eculizumab for the Treatment of Recurrent C3 Glomerulonephritis Caused by C3 Gain of Function Mutation

Authors

Joon S. Kim, University of Nebraska Medical CenterFollow
Ryan P. Mullane, University of Nebraska Medical CenterFollow
Scott Westphal, University of Nebraska Medical CenterFollow
Eric Langewisch, University of Nebraska Medical CenterFollow
Clifford Miles, University of Nebraska Medical CenterFollow

Document Type

Conference Proceeding

Disciplines

Higher Education | Medicine and Health Sciences

DOI

10.32873/unmc.dc.gmerj.1.1.072

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.

Recommended Citation

Kim, J. S., Mullane, R. P., Westphal, S., Langewisch, E., , Miles, C. Eculizumab for the Treatment of Recurrent C3 Glomerulonephritis Caused by C3 Gain of Function Mutation. Graduate Medical Education Research Journal. 2019 Dec 13; 1(1).
https://digitalcommons.unmc.edu/gmerj/vol1/iss1/72